Whoop CEO Will Ahmed on Thursday said the wearable technology company’s blood pressure tool is a wellness use case that should not fall under the Food and Drug Administration’s jurisdiction for regulation.
Thursday, August 14
By webmaster
Whoop CEO Will Ahmed on Thursday said the wearable technology company’s blood pressure tool is a wellness use case that should not fall under the Food and Drug Administration’s jurisdiction for regulation.
